• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用吸烟状况和吸烟强度指标评估严重 COVID-19 结局。

Assessment of Severe COVID-19 Outcomes Using Measures of Smoking Status and Smoking Intensity.

机构信息

Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.

Division of Epidemiology, Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.

出版信息

Int J Environ Res Public Health. 2021 Aug 25;18(17):8939. doi: 10.3390/ijerph18178939.

DOI:10.3390/ijerph18178939
PMID:34501529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8431679/
Abstract

OBJECTIVE

Smoking status does not indicate the amount or length of tobacco use, and thus, it is an imperfect measure to assess the association between cigarette smoking and severe coronavirus disease 2019 (COVID-19) outcomes. This investigation assessed whether cigarette smoking status, intensity of smoking (i.e., average daily packs of cigarettes smoked), duration of smoking, and pack-years of smoking are associated with severe outcomes among adults diagnosed with COVID-19.

METHODS

We conducted a retrospective, cross-sectional study in which we identified consecutive patients diagnosed with COVID-19 at the University of Cincinnati healthcare system between 13 March 2020 and 30 September 2020 who had complete information on smoking status, severe COVID-19 outcomes, and covariates (i.e., demographics and comorbidities). We used logistic regression to evaluate the associations of smoking status and intensity of smoking with COVID-19 severity, defined as hospitalization, admission to intensive care unit (ICU), or death, adjusting for sociodemographics and comorbidities.

RESULTS

Among the 4611 COVID-19 patients included in the analysis, 18.2% were current smokers and 20.7% were former smokers. The prevalence of COVID-19 outcomes was 28.9% for hospitalization, 9.8% for ICU admission, and 1.4% for death. In the adjusted analysis, current smoking (AOR: 1.23, 95% CI: 1.02-1.49), former smoking (AOR: 1.28, 95% CI: 1.07-1.54), and pack-years of smoking (AOR: 1.09, 95% CI: 1.02-1.17) were associated with a higher prevalence of hospitalization. Average daily packs of cigarettes smoked was associated with a higher prevalence of hospitalization (AOR: 1.30, 95% CI: 1.10-1.53) and ICU admission (AOR: 1.23, 95% CI: 1.04-1.44).

CONCLUSIONS

Smoking status, pack-years, and intensity of smoking were associated with hospitalizations in patients with COVID-19 and intensity of smoking was associated with ICU admission. The findings underscore the need for detailed information beyond smoking status when evaluating smokers with COVID-19 so that the potential for adverse sequelae may be optimally managed in at-risk patients.

摘要

目的

吸烟状况并不能表明吸烟量或吸烟时间的长短,因此,用它来评估吸烟与严重 2019 冠状病毒病(COVID-19)结局之间的关系并不准确。本研究评估了成年 COVID-19 患者的吸烟状况、吸烟强度(即平均每日吸烟包数)、吸烟持续时间和吸烟年包数是否与严重结局相关。

方法

我们进行了一项回顾性、横断面研究,在这项研究中,我们确定了在 2020 年 3 月 13 日至 2020 年 9 月 30 日期间,在辛辛那提大学医疗系统被诊断为 COVID-19 的连续患者,这些患者的吸烟状况、COVID-19 严重结局以及协变量(即人口统计学和合并症)的信息完整。我们使用逻辑回归来评估吸烟状况和吸烟强度与 COVID-19 严重程度(定义为住院、入住重症监护病房(ICU)或死亡)之间的关联,同时调整了社会人口统计学和合并症因素。

结果

在纳入分析的 4611 名 COVID-19 患者中,18.2%为当前吸烟者,20.7%为前吸烟者。住院、入住 ICU 和死亡的 COVID-19 结局发生率分别为 28.9%、9.8%和 1.4%。在调整后的分析中,当前吸烟(OR:1.23,95%CI:1.02-1.49)、前吸烟(OR:1.28,95%CI:1.07-1.54)和吸烟年包数(OR:1.09,95%CI:1.02-1.17)与住院率较高相关。平均每日吸烟包数与住院率(OR:1.30,95%CI:1.10-1.53)和 ICU 入住率(OR:1.23,95%CI:1.04-1.44)较高相关。

结论

吸烟状况、吸烟年包数和吸烟强度与 COVID-19 患者的住院有关,而吸烟强度与 ICU 入住有关。这些发现强调了在评估 COVID-19 吸烟者时,需要超越吸烟状况提供更详细的信息,以便在高危患者中优化管理潜在的不良后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc97/8431679/fde635dd5d47/ijerph-18-08939-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc97/8431679/fde635dd5d47/ijerph-18-08939-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc97/8431679/fde635dd5d47/ijerph-18-08939-g001.jpg

相似文献

1
Assessment of Severe COVID-19 Outcomes Using Measures of Smoking Status and Smoking Intensity.使用吸烟状况和吸烟强度指标评估严重 COVID-19 结局。
Int J Environ Res Public Health. 2021 Aug 25;18(17):8939. doi: 10.3390/ijerph18178939.
2
Tobacco Smoking and Risk of SARS-CoV-2 Infection and Disease Severity Among Adults in an Integrated Healthcare System in California.加州综合医疗体系中成年人吸烟与感染 SARS-CoV-2 及疾病严重程度的关系。
Nicotine Tob Res. 2023 Jan 5;25(2):211-220. doi: 10.1093/ntr/ntac090.
3
Smoking Status, Nicotine Medication, Vaccination, and COVID-19 Hospital Outcomes: Findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study.吸烟状况、尼古丁药物、疫苗接种与 COVID-19 住院结局:威斯康星大学 COVID 电子健康记录队列(CEC-UW)研究结果。
Nicotine Tob Res. 2023 May 22;25(6):1184-1193. doi: 10.1093/ntr/ntac201.
4
Association between smoking, e-cigarette use and severe COVID-19: a cohort study.吸烟、电子烟使用与严重 COVID-19 之间的关联:一项队列研究。
Int J Epidemiol. 2022 Aug 10;51(4):1062-1072. doi: 10.1093/ije/dyac028.
5
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.疾病修正疗法与多发性硬化症中 COVID-19 严重程度的关联。
Neurology. 2021 Nov 9;97(19):e1870-e1885. doi: 10.1212/WNL.0000000000012753. Epub 2021 Oct 5.
6
Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy.评估抗 TNF 治疗的强直性脊柱炎患者 COVID-19 的频率和强度。
Turk J Med Sci. 2022 Apr;52(2):522-523. doi: 10.55730/1300-0144.5341. Epub 2022 Apr 14.
7
Controversy over smoking in COVID-19-A real world experience in New York city.关于 COVID-19 期间吸烟的争议-纽约市的真实世界经验。
J Med Virol. 2021 Jul;93(7):4537-4543. doi: 10.1002/jmv.26738. Epub 2021 Mar 25.
8
The Impact of Smoking Status and Smoking-Related Comorbidities on Coronavirus Disease 2019 Patient Outcomes: A Causal Mediation Analysis.吸烟状况及与吸烟相关的合并症对 2019 年冠状病毒病患者结局的影响:因果中介分析。
Nicotine Tob Res. 2023 Jan 5;25(2):331-338. doi: 10.1093/ntr/ntac193.
9
Cannabis, Tobacco Use, and COVID-19 Outcomes.大麻、烟草使用与 COVID-19 结局。
JAMA Netw Open. 2024 Jun 3;7(6):e2417977. doi: 10.1001/jamanetworkopen.2024.17977.
10
Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey.吸烟与 SARS-CoV-2 感染的相关性:基于互联网的 EPICOVID19 调查的横断面研究。
JMIR Public Health Surveill. 2021 Apr 28;7(4):e27091. doi: 10.2196/27091.

引用本文的文献

1
Risk profiles for smoke behavior in COVID-19: a classification and regression tree analysis approach.COVID-19 中烟雾行为的风险特征:分类回归树分析方法。
BMC Public Health. 2023 Nov 21;23(1):2302. doi: 10.1186/s12889-023-17224-z.
2
Association between cigarette smoking patterns and severity of COVID-19: Findings from a study in 15 private Hospitals in Indonesia.吸烟模式与COVID-19严重程度之间的关联:印度尼西亚15家私立医院的一项研究结果
Tob Induc Dis. 2023 Feb 17;21:27. doi: 10.18332/tid/159622. eCollection 2023.
3
Assessing Smoking Status and Risk of SARS-CoV-2 Infection: A Machine Learning Approach among Veterans.

本文引用的文献

1
Role of Cigarette Smoke on Angiotensin-Converting Enzyme-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model.使用气液界面模型研究香烟烟雾对支气管上皮细胞中血管紧张素转换酶2蛋白膜表达的作用。
Front Pharmacol. 2021 Mar 30;12:652102. doi: 10.3389/fphar.2021.652102. eCollection 2021.
2
On the road to ending the COVID-19 pandemic: Are we there yet?走向终结新冠大流行之路:我们是否已经到达终点?
Virology. 2021 May;557:70-85. doi: 10.1016/j.virol.2021.02.003. Epub 2021 Feb 26.
3
Smoking and COVID-19: A Scoping Review.
评估吸烟状况与新型冠状病毒2感染风险:退伍军人中的一种机器学习方法
Healthcare (Basel). 2022 Jul 4;10(7):1244. doi: 10.3390/healthcare10071244.
4
Comorbidities in childhood-onset and adult-onset asthma.儿童期起病和成人期起病哮喘的合并症
Ann Allergy Asthma Immunol. 2022 Sep;129(3):327-334. doi: 10.1016/j.anai.2022.05.005. Epub 2022 May 18.
吸烟与2019冠状病毒病:一项范围综述
Tob Use Insights. 2021 Feb 15;14:1179173X21994612. doi: 10.1177/1179173X21994612. eCollection 2021.
4
The coronavirus is here to stay - here's what that means.新冠病毒将长期存在——以下是这意味着什么。
Nature. 2021 Feb;590(7846):382-384. doi: 10.1038/d41586-021-00396-2.
5
Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis.新冠病毒肺炎患者吸烟与不良结局风险:一项系统评价与荟萃分析
Tob Induc Dis. 2021 Feb 4;19:09. doi: 10.18332/tid/132411. eCollection 2021.
6
Association of Smoking and Cumulative Pack-Year Exposure With COVID-19 Outcomes in the Cleveland Clinic COVID-19 Registry.吸烟和累计吸烟包年数与克利夫兰诊所 COVID-19 注册中心 COVID-19 结局的关联。
JAMA Intern Med. 2021 May 1;181(5):709-711. doi: 10.1001/jamainternmed.2020.8360.
7
Smoking, development of or recovery from metabolic syndrome, and major adverse cardiovascular events: A nationwide population-based cohort study including 6 million people.吸烟、代谢综合征的发生或恢复以及主要不良心血管事件:一项包括 600 万人的全国性基于人群的队列研究。
PLoS One. 2021 Jan 12;16(1):e0241623. doi: 10.1371/journal.pone.0241623. eCollection 2021.
8
The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis.吸烟对新冠病毒疾病症状严重程度的影响:系统评价与荟萃分析
Pulm Med. 2020 Sep 8;2020:7590207. doi: 10.1155/2020/7590207. eCollection 2020.
9
Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice.吸烟、严重急性呼吸综合征冠状病毒2与冠状病毒病2019:关于对公共卫生政策与实践影响的综述之综述
Tob Induc Dis. 2020 Jul 3;18:58. doi: 10.18332/tid/124788. eCollection 2020.
10
Smoking Is Associated With COVID-19 Progression: A Meta-analysis.吸烟与 COVID-19 进展相关:一项荟萃分析。
Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656. doi: 10.1093/ntr/ntaa082.